These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 32495012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety of apixaban and rivaroxaban in patients with atrial fibrillation on hemodialysis.
    Ito H.
    Eur J Intern Med; 2024 Jun; 124():154-155. PubMed ID: 38342714
    [No Abstract] [Full Text] [Related]

  • 4. [Good efficacy and safety profile in clinical practice].
    MMW Fortschr Med; 2015 Nov 19; 157(20):66-7. PubMed ID: 26977521
    [No Abstract] [Full Text] [Related]

  • 5. Greater Risk of Serious Bleeding With Diltiazem vs. Metoprolol in Adults With Atrial Fibrillation Using Apixaban or Rivaroxaban.
    Slawson DC.
    Am Fam Physician; 2024 Aug 19; 110(2):203. PubMed ID: 39172685
    [No Abstract] [Full Text] [Related]

  • 6. [Acute tubulo-interstitial nephritis due to RIVAROXABAN (XARELTO)].
    Dantec A, Virot JS, Filancia A, Angonin R, Nefti H.
    Presse Med; 2017 May 19; 46(5):541-542. PubMed ID: 28483286
    [No Abstract] [Full Text] [Related]

  • 7. Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis.
    Lindner SM, Fordyce CB, Hellkamp AS, Lokhnygina Y, Piccini JP, Breithardt G, Mahaffey KW, Singer DE, Hacke W, Halperin JL, Hankey GJ, Berkowitz SD, Nessel CC, Becker RC, Fox KA, Patel MR, ROCKET AF Steering Committee and Investigators.
    Circulation; 2017 Mar 07; 135(10):1001-1003. PubMed ID: 28264892
    [No Abstract] [Full Text] [Related]

  • 8. Rivaroxaban-associated intracranial hemorrhage in Saudi atrial fibrillation patients.
    Alkhotani A, Alrishi N, Alharthi M, Alzahrani W.
    Medicine (Baltimore); 2020 Nov 25; 99(48):e23316. PubMed ID: 33235091
    [Abstract] [Full Text] [Related]

  • 9. Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
    Tamayo SG, Simeone JC, Nordstrom BL, Patel MR, Yuan Z, Sicignano NM, Peacock WF.
    J Am Coll Cardiol; 2016 Sep 06; 68(10):1144-6. PubMed ID: 27585515
    [No Abstract] [Full Text] [Related]

  • 10. [Real life clinical management of nonvalvular atrial fibrillation: results from the Italian epidemiological survey eXperience on the use of rivaroxaban].
    Colonna P, Ammirati F, a nome del Gruppo Italiano eXperience.
    G Ital Cardiol (Rome); 2016 Nov 06; 17(11):932-939. PubMed ID: 27996999
    [Abstract] [Full Text] [Related]

  • 11. CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban.
    Peacock WF, Tamayo S, Patel M, Sicignano N, Hopf KP, Yuan Z.
    Ann Emerg Med; 2017 May 06; 69(5):541-550.e1. PubMed ID: 27913059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy.
    Sholzberg M, Xu Y.
    JAMA; 2018 Oct 09; 320(14):1485-1486. PubMed ID: 30242329
    [No Abstract] [Full Text] [Related]

  • 17. Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation.
    Kido K, Shimizu M, Shiga T, Hashiguchi M.
    Am J Cardiol; 2020 Nov 01; 134():160-161. PubMed ID: 32916147
    [No Abstract] [Full Text] [Related]

  • 18. Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation.
    Aronow WS, Shamliyan TA.
    Am J Ther; 2019 Nov 01; 26(6):e679-e703. PubMed ID: 30461433
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.
    Bundhun PK, Soogund MZ, Teeluck AR, Pursun M, Bhurtu A, Huang WQ.
    BMC Cardiovasc Disord; 2017 Jan 06; 17(1):15. PubMed ID: 28056795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.